News A two-layer safeguard for stem cell identityPublished:09.03.26 — EPFL researchers uncover how two proteins work together to prevent stem cells from activating the wrong genetic programs.Three promotions in the Life SciencesPublished:09.03.26 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL. Among them, Elisa Oricchio (ISREC), Jacques Fellay (GHI) and Bruno Correia (IBI) have been promoted to Full Professors.When light boosts protein evolutionPublished:09.03.26 — EPFL researchers have developed a light-based method that can produce proteins that switch states, respond to signals, and even compute, using light and the cell cycle.EPFL joins $25 million research on cancer avoidancePublished:04.03.26 — Jacques Fellay’s lab at EPFL will lead data integration and analysis within the Cancer Grand Challenges ATLAS team, selected to investigate why some high-risk individuals never develop cancer.A promising new drug for an invasive type of breast cancerPublished:26.02.26 — EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical trials.
